arrow
返回
M

Matthew D. Galsky

icahn school of medicine at mount sinai

79H指数
851论文数
3.4W被引数
收录论文 253
发表时间
TROPION-Urothelial03: a phase II/III study of datopotamab deruxtecan (Dato-DXd) for locally advanced or metastatic urothelial carcinomaTROPION-Urothelial03:达波替安德鲁克坦(Dato-DXd)治疗局部晚期或转移性尿路上皮癌的II/III期研究
err2026-05-16
err0
PREAI
errMatthew D. Galsky; Alexandra Drakaki; Arnab Basu; Bradley McGregor; Jens Bedke; Yohann Loriot; Eiji Kikuchi; Jun Guo; Benjamin Garmezy; Srikala S. Sridhar; Parminder Singh; Vadim S. Koshkin; Mark Fleming; Gunnar Klauss; Daisy Lin; Chelsea Liu; Andrea B. Apolo; Thomas Powles
err分享
err收藏
How enfortumab vedotin plus pembrolizumab affects the quality of life of people with advanced urothelial cancer compared with platinum-based chemotherapy: a plain language summary of patient-reported outcomes from the EV-302 study恩福妥单抗联合帕博利珠单抗与铂类化疗相比对晚期尿路上皮癌患者生活质量的影响:EV-302研究患者报告结局的通俗语言摘要
err2026-04-01
err0
PREAI
errGupta, Shilpa; Loriot, Yohann; Van der Heijden, Michiel S.; Bedke, Jens; Valderrama, Begona P.; Kikuchi, Eiji; Flechon, Aude; Petrylak, Daniel; De Santis, Maria; Galsky, Matthew D.; Lee, Jae Lyun; Swami, Umang; Sridhar, Srikala S.; De Giorgi, Ugo; Wright, Phoebe; Shih, Vanessa; Lu, Yi-Tsung; Guan, Xuesong; Dillon, Ryan; Shetty, Aditya; Homet Moreno, Blanca; Beaumont, Jennifer L.; Purnajo, Intan; McManus, Shauna; Powles, Thomas
err分享
err收藏
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers高级泌尿肿瘤共识会议(AUC3)2025:肾细胞癌和尿路肿瘤管理的专家共识
err2025-12-13
err0
errOAAI
errRana R. McKay MD; Sumanta Pal MD; Wanling Xie MS; David Aggen MD, PhD; Laurence Albiges MD, PhD; Andrea Apolo MD; Michael B. Atkins MD; Rick Bangs MBA, PMP; Kathryn E. Beckermann MD, PhD; Joaquim Bellmunt MD, PhD; Stephanie A. Berg DO; Mehmet A. Bilen MD; David Braun MD, PhD; Maria I. Carlo MD; Jason Efstathiou MD, DPhil; Matthew Galsky MD; Petros Grivas MD, PhD; Shilpa Gupta MD; Naomi Haas MD; A. Ari Hakimi MD; Hans Hammers MD, PhD; Daniel Y. C. Heng MSC; Michelle Hirsch MD, PhD; Gopakumar Iyer MD; Eric Jonasch MD; Vadim S. Koshkin MD; Oleksandr Kryvenko MD; Bryan Lewis JD; Roger Li MD; Surena Matin MD; Benjamin Maughan MD, PharmD; David F. McDermott MD; Bradley McGregor MD; Joshua Meeks MD, PhD; Matthew Milowsky MD; Robert Motzer MD; Andrea Necchi MD; Dan Petrylak MD; Sima Porten MD, MPH; Thomas Powles MBBS, MRCP, MD; Brian Rini MD; Brian Shuch MD; Arlene Siefker-Radtke MD; Guru Sonpavde MD; S. Srikala Sridhar MD; Cristina Suarez MD, PhD; Chad Tang MD; Abhishek Tripathi MD; Michiel S. Van Der Heijden MD, PhD; Martin Voss MD; Wenxin Xu MD; Tian Zhang MD; Jonathan Rosenberg MD; Toni K. Choueiri MD
err分享
err收藏
Prostate cancer in situ autovaccination with the intratumoral viral mimic poly-ICLC: Modulating the cold tumor microenvironment前列腺原位自体疫苗接种与肿瘤内注射病毒模拟物poly-ICLC:调节冷肿瘤微环境
errMed
IF11.8
err2025-10-30
err0
errOAAI
errSujit S. Nair; Dimple Chakravarty; Sreekumar Balan; Alexander Hakansson; Manuel Duval; Elai Davicioni; Yang Liu; Swati Bhardwaj; Tin Htwe Thin; Monica Garcia-Barros; Kenneth Haines; Majd Al Shaarani; Rachel Weil; Marcia Meseck; Parita Ratnani; Monali Fatterpekar; Elena Gonzalez-Gugel; Adam Farkas; Vinayak Wagaskar; Ivan Jambor; Kacie Schlussel; Cristina Pasat-karasik; Kamala Bhatt; Zachary Dovey; Adriana Pedraza; Akriti Gupta; Dara Lundon; Ante Peros; Sneha Parekh; Lily Davenport; Xiangfu Zhang; Raghav Gupta; Macy Robison; Cynthia Knauer; Ethan Ellis; Dmitry Rykunov; Boris Reva; Babu Padanilam; Matthew D. Galsky; Rachel Brody; Mani Menon; Andres M. Salazar; Nina Bhardwaj; Ashutosh K. Tewari
err分享
err收藏
Adjuvant nivolumab versus placebo for high-risk muscle-invasive urothelial carcinoma: 5-year efficacy and ctDNA results from CheckMate 274高风险肌层浸润性尿路上皮癌的辅助尼洛替尼对比安慰剂:CheckMate 274研究的5年疗效和ctDNA结果
err2025-10-17
err0
errOAAI
errM.D. Galsky; J.E. Gschwend; M.I. Milowsky; M. Schenker; B.P. Valderrama; Y. Tomita; A. Bamias; T. Lebret; S.F. Shariat; S.H. Park; M. Agerbaek; G. Jha; F. Stenner; D. Ye; F. Giudici; J. Connors; S. Gupta; A. Chhibber; J. Zhang; D.F. Bajorin; J.A. Witjes
err分享
err收藏
Clinical utility of tumour-informed circulating tumour DNA in patients with testicular cancer肿瘤知情循环肿瘤DNA在睾丸癌患者中的临床应用价值
err2025-10-07
err0
PREAI
errReuben Ben-David; Ahmed Eraky; Brenda Hug; Matthew D. Galsky; Che-Kai Tsao; Kyrollis Attalla; Peter Wiklund; Reza Mehrazin; John P. Sfakianos
err分享
err收藏
Documentation of patient withdrawals, retention strategies, and postwithdrawal data practices in cancer clinical trials癌症临床试验中患者退出记录、留置策略及退出后数据处理实践的文档化
errCancer
IF5.1
err2025-09-26
err0
PREAI
errAlexander B. Karol MD; Rodrigo Paredes MD; Anna Argulian BS; Himanshu Joshi MBBS, PhD; Lexi Weintraub BS; Kasopefoluwa Oguntuyo MD, PhD; Justin Miller BS; Yu Fujiwara MD; Deborah B. Doroshow MD, PhD; Matthew D. Galsky MD
err分享
err收藏
HER2 and urothelial carcinoma: current understanding and future directionsHER2与尿路上皮癌:当前认知与未来方向
err2025-08-15
err0
PREAI
errDaniele Raggi; Emanuele Crupi; Filippo Pederzoli; Alberto Martini; Alberto Briganti; Omar Alhalabi; Peter H. O’Donnell; Jeffrey Ross; Shilpa Gupta; Ashish M. Kamat; Bishoy M. Faltas; Peter C. Black; Phillip E. Spiess; Petros Grivas; Jianjun Gao; Andrea B. Apolo; Robert A. Huddart; Andrea Necchi; Matthew D. Galsky
err分享
err收藏
Adjuvant nivolumab in muscle-invasive urothelial carcinoma: exploratory biomarker analysis of the randomized phase 3 CheckMate 274 trial辅助性纳武利尤单抗在肌肉浸润性尿路上皮癌中的应用:随机III期CheckMate 274试验的探索性生物标志物分析
err2025-08-07
err0
PREAI
errMatthew D. Galsky; Dean F. Bajorin; Yoshihiko Tomita; Dingwei Ye; Mads Agerbaek; Deborah Enting; Avivit Peer; Matthew Milowsky; Ko Kobayashi; Marc-Oliver Grimm; Frank Stenner; Justin M. David; Jun Li; Scott D. Chasalow; Federico Nasroulah; Abraham Apfel; Keziban Ünsal-Kaçmaz; Andrea Necchi
err分享
err收藏
Pathogenic Genomic Alterations in Circulating Tumor DNA Predict Overall Survival in Men with Metastatic Castrate-resistant Prostate Cancer循环肿瘤DNA中的致病基因组改变可预测转移性去势抵抗性前列腺癌患者的总生存期
err2025-08-06
err0
PREAI
errSusan Halabi; Siyuan Guo; Bin Luo; Chenxi Yu; Todd P. Knutson; Anna Kobilka; Jacqueline Lyman; Himisha Beltran; Emmanuel S. Antonarakis; Matthew D. Galsky; Jonathan E. Rosenberg; Charles J. Ryan; Eric J. Small; W.Kevin Kelly; Michael J. Morris; David Page; Scott M. Dehm; Andrew J. Armstrong
err分享
err收藏
SGNDV-001: disitamab vedotin with pembrolizumab in HER2-expressing locally advanced or metastatic urothelial carcinomaSGNDV-001: 西迪妥单抗维多汀联合帕博利珠单抗治疗表达HER2的局部晚期或转移性尿路上皮癌
err2025-07-29
err0
errOAAI
errThomas B. Powles; Enrique Grande; Nimira Alimohamed; Niara Oliveira; Srikala S. Sridhar; Alexandra Drakaki; Ravindran Kanesvaran; Yohann Loriot; Andrea Necchi; Sonia Franco; Dingfeng Jiang; Kristel Apolinario; Wei Zhang; Matthew D. Galsky
err分享
err收藏
Author Correction: Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial作者更正: Sasanlimab加BCG在BCG幼稚,高危非肌层浸润性膀胱癌中的应用: 随机3期CREST试验
err2025-07-21
err0
errOAAI
errNeal D. Shore; Thomas B. Powles; Jens Bedke; Matthew D. Galsky; Joan Palou Redorta; Ja Hyeon Ku; Michal Kretkowski; Evanguelos Xylinas; Boris Alekseev; Dingwei Ye; Félix Guerrero-Ramos; Alberto Briganti; Girish S. Kulkarni; Julia Brinkmann; Anna-Maria Calella; Rossano Cesari; Anthony Eccleston; Elisabete Michelon; Jennifer Vermette; Caimiao Wei; Gary D. Steinberg
err分享
err收藏
Enfortumab vedotin plus pembrolizumab versus chemotherapy in patients with previously untreated locally advanced or metastatic urothelial cancer (EV-302): patient-reported outcomes from an open-label, randomised, controlled, phase 3 study恩诺单抗维多汀联合帕博利珠单抗对比化疗在先前未经治疗的局部晚期或转移性尿路上皮癌患者中的疗效(EV-302):一项开放标签、随机对照、III期研究的患者报告结局
err2025-05-28
err0
PREAI
errShilpa Gupta; Yohann Loriot; Michiel S Van der Heijden; Jens Bedke; Begoña P Valderrama; Eiji Kikuchi; Aude Fléchon; Daniel Petrylak; Maria De Santis; Matthew D Galsky; Jae Lyun Lee; Umang Swami; Srikala S Sridhar; Ugo De Giorgi; Phoebe Wright; Vanessa Shih; Yi-Tsung Lu; Xuesong Guan; Ryan Dillon; Aditya Shetty; Blanca Homet Moreno; Jennifer L Beaumont; Intan Purnajo; Shauna McManus; Thomas Powles
err分享
err收藏
Characterization of Patients with Lymph Node Only Metastatic Urothelial Carcinoma Treated with Nivolumab Plus Gemcitabine-Cisplatin Versus Gemcitabine-Cisplatin Alone from the CheckMate 901 TrialCheckMate 901试验中,仅淋巴结转移性尿路上皮癌患者接受纳武利尤单抗联合吉西他滨-顺铂治疗与单独吉西他滨-顺铂治疗的特征分析
err2025-05-20
err0
errOAAI
errMatthew D. Galsky; Michiel S. van der Heijden; Thomas Powles; Melanie Claps; Mauricio Burotto; Michael Schenker; Juan Pablo Sade; Aristotelis Bamias; Philippe Beuzeboc; Jens Bedke; Jan Oldenburg; Yüksel Ürün; Dingwei Ye; Begoña P. Valderrama; Yoshihiko Tomita; Ruiyun Jiang; Jeiry Filian; Lily Wang; Maximiliano van Kooten Losio; Guru Sonpavde
err分享
err收藏
PrECOG PrE0807: A Phase 1b Feasibility Trial of Neoadjuvant Nivolumab Without and with Lirilumab in Patients with Muscle-invasive Bladder Cancer Ineligible for or Refusing Cisplatin-based Neoadjuvant Chemotherapy
err2024-08-01
err5
PREAI
errGrivas, Petros; Koshkin, Vadim S.; Chu, Xiangying; Cole, Suzanne; Jain, Rohit K.; Dreicer, Robert; Cetnar, Jeremy P.; Sundi, Debasish; Gartrell, Benjamin A.; Galsky, Matthew D.; Woo, Brianna; Li-Ning-Tapia, Elsa; Hahn, Noah M.; Carducci, Michael A.
err分享
err收藏